Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung
about
Surgical pathology of early stage non-small cell lung carcinomaClinical impacts of a micropapillary pattern in lung adenocarcinoma: a reviewLung cancer screening: past, present and futureThe new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issuesAdvances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)The pivotal role of pathology in the management of lung cancerSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerPrognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancerMapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.Prognostic factors in resected lung carcinomas.Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer PrognosisC4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaOncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinomaRecent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomasPrognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I diseaseRisk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patientsThe new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinomaComparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinomaCorrelation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should knowDifferences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer"One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncologyThe cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.Clinical features and mutation status of EGFR, KRAS, BRAF, EML4-ALK and ROS1 between surgical resection samples and non surgical resection samples in lung cancer.Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.CT-guided fine-needle localization of ground-glass nodules in re-aerated lung specimens: localization of solitary small nodules or multiple nodules within the same lobe.Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samplesThe prognostic and predictive value of solid subtype in invasive lung adenocarcinoma.Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutationPredominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail?
P2860
Q26739713-09DD06A5-0306-48FD-B4B2-CDC778CB8818Q26771950-B83F5C37-5CC3-4500-98E8-D9CB9025AE62Q26829339-33B49ABD-6B34-4860-BCC4-8DEE0CB0777CQ26864736-4C2BD26F-3637-40BD-8E4A-43AA1F8D6FD4Q27009370-EC65A99F-B353-4DDD-9267-63F595B4AEC9Q27010437-F338CD2A-5601-448B-A0D2-F2C8E7638595Q28816916-A9A0A978-8B5F-49CE-90FD-4FE3F88685DCQ31034428-133A8BAF-89E3-4E14-96A6-426716845354Q33582932-66A4C9CD-B485-48CB-9C62-7299F0FCB25BQ33645624-1CDEC302-3CED-4368-BA7D-7E031415920BQ33688542-9802176F-7F89-4DA3-AEC0-B874603EFA51Q33697964-B2E3031B-A7E5-42BD-8D4A-AAE5F35ECF73Q33772555-765A605E-E83A-4136-9045-CD54F990B96CQ34031219-227BC576-BCB3-446D-B338-9329CB0CA1EDQ34073766-A84855A0-D417-4C0E-B157-6484521E3A20Q34141249-916B8BF4-B113-4D32-AF03-F987A836E612Q34181641-873884DD-C645-470D-9308-BC7A623E36B7Q34208219-2D90AF78-EE95-4948-8A61-3A16885B9DC7Q34404266-EB82468B-89E4-496D-BC95-A740A83E90A1Q34406294-33A8FE04-27E6-4711-B880-2C5D7140E7F4Q34567000-1F9E6641-2CAE-4DE1-B863-952366CE6E4EQ34732930-B050F6D7-52B8-4F4B-B69D-847F77F541EBQ34748124-2B0762C3-47BD-4068-8B15-27A4EB7F637EQ34752733-0A0E8776-F842-48E4-A563-FF3E8B66FB63Q34814550-022F66CC-1A72-4790-ADBB-732D19AD4D55Q35055942-F22C2451-9037-489A-BC91-37A779F0E606Q35219157-048C860F-3405-41E8-8E8E-1068A0C63CE3Q35681021-F608E885-F154-4AE8-A184-9BE2C23D8374Q35764518-EAFEE79B-C829-4A96-B0B2-278734A625F0Q35838494-209027DF-6B25-4315-848B-F487927B9918Q35954585-5AB63393-A906-4DF9-A71F-6FA73D1B1ACDQ36013991-EA4BFEED-BE33-497B-AF4C-1CBDF2C517DDQ36018723-F3202047-79A0-4FA1-97B8-127978B41C25Q36162509-8A0740C0-138D-4361-BAEE-556E6A7CD6D0Q36162516-A788FD1A-7C09-486C-BAA1-49C35D80FF18Q36250691-5FD956EA-65D7-4B7C-B849-BE96BEF2A462Q36261427-528DE067-0267-4D19-8756-C961F8859096Q36294486-04443C72-3C4D-4B69-BE67-E049038EA8D5Q36337437-B735EDCE-F97C-4FB1-9352-F0E0CB3544D3Q36474217-B589B39B-B2EA-4DFA-A573-60B68215BF43
P2860
Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@ast
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@en
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@nl
type
label
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@ast
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@en
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@nl
prefLabel
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@ast
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@en
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@nl
P2093
P1476
Does lung adenocarcinoma subty ...... ational multidisciplinary lung
@en
P2093
Gavin M Wright
Marissa Daniels
Matthew Conron
Prudence A Russell
Richard A Williams
Zoe Wainer
P304
P356
10.1097/JTO.0B013E318221F701
P577
2011-09-01T00:00:00Z